Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Research

Multiple obesity indices suggest a close relationship between obesity and constipation: evidence from NHANES

verfasst von: Nengjun Xiang, Lulu Xu, Haihua Qian, Dan Zhang

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Objective

This study aims to investigate the relationship between obesity and constipation among American adults.

Methods

Our study leveraged data from the National Health and Nutrition Examination Survey (NHANES). This comprehensive approach enabled us to summarize the weighted prevalence rates of obesity in adults. To further deepen our understanding, we employed a variety of analytical methods. These included multivariable logistic regression, subgroup analysis and restricted cubic splines. Through these methodologies, we were able to effectively evaluate the correlation between various obesity indicators and constipation, offering new insights into this complex relationship.

Results

The weighted prevalence of constipation stands at 9.42%. Notably, an increased risk of constipation is linked with a BMI (body mass index) exceeding 28 kg/m2, WSR (waist-stature ratio) that is either between 58.3 and 64.8 or above 64.8, as well as a LAP (lipid accumulation products) ranging from 50.8 to 90.1. In contrast, a reduced risk of constipation is associated with WWI (weight-adjusted-waist index) that falls between 0.015 and 0.020, exceeds 0.020, and without the presence of central obesity (P < 0.05). Restricted cubic spline analysis, a significant non-linear relationship was discerned between BMI, WSR, and LAP in relation to constipation.

Conclusions

This pioneering large-scale study explores the relationship between various obesity indices and constipation. It reveals that reducing the BMI, WSR, LAP and waist circumference can decrease the risk of constipation. Conversely, a higher value of WWI correlates with a lower constipation risk, and this remains true even after adjusting for a wide range of variables.
Hinweise
Nengjun Xiang and Lulu Xu contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
RCS
Restricted Cubic Spline
BSFS
Bristol Stool Form Scale
VAI
Visceral Adiposity Index
WWI
Weight-adjusted-waist Index
WSR
Waist-stature Ratio
LAP
Lipid Accumulation Products
BMI
Body Mass Index
PIR
Poverty Income Ratio
WC
Waist Circumference
NHANES
National Health and Nutrition Examination Survey

Introduction

Global obesity rates are on the rise [1], presenting a significant challenge to public health. According to the ‘2017 Global Nutrition Report’ more than 2 billion adults worldwide are either overweight or obese. This concerning trend is rooted in the fact that obesity isn’t just linked to an increased risk of cardiovascular diseases, diabetes, and specific cancers; it also serves as a crucial predictor of metabolic disorders. Furthermore, obesity shows a significant association with various digestive system ailments, primarily attributable to the excessive accumulation of fat [2].
Among these conditions, chronic constipation stands out as a common gastrointestinal disorder, affecting roughly 16% of adults worldwide [3]. It deserves attention due to its adverse impact on quality of life and its potential to lead to severe health complications. Research, including a study conducted on Italian residents, has suggested a higher prevalence of constipation among obese individuals [4], potentially linked to their dietary habits and levels of physical activity [5]. Obesity may indirectly contribute to constipation through mechanisms such as the alteration of intestinal hormone secretion, impaired intestinal motility, and inflammatory responses. However, other studies, particularly those involving American adults, propose a contrasting view that there is no direct correlation between being overweight and experiencing constipation [6, 7]. This discrepancy underscores the need for further research in this field.
Visceral obesity is typically quantified using computed tomography (CT) or magnetic resonance imaging (MRI) [8]. To avoid high costs and exposure to electromagnetic radiation, body mass index (BMI) and waist circumference (WC) are more commonly employed to assess visceral obesity [9, 10]. However, recent years have witnessed the emergence of indices that combine anthropometric measurements with lipid values, such as the visceral adiposity index (VAI) and lipid accumulation products (LAP). These indices have demonstrated higher accuracy in identifying visceral obesity [11].
The primary aim of our study is to investigate the relationship between various definitions of obesity, including VAI, weight-adjusted waist index (WWI), waist-stature ratio (WSR), LAP, BMI, and waist-based central obesity, in relation to constipation while controlling for confounding factors. LAP, a cost-effective index, is frequently used to assess obesity from multiple perspectives [12]. Our multidimensional approach to obesity assessment encompasses various aspects, ranging from fat distribution to metabolic risk, offering a comprehensive perspective on how obesity impacts intestinal health.
This paper systematically reviews and analyzes the correlation between these obesity indicators and the prevalence of constipation. Our objective is to elucidate the individual and combined effects of these indicators on the development of constipation. To accomplish this, we leverage a large dataset from the National Health and Nutrition Examination Survey (NHANES) database, along with genome-wide association study (GWAS) pooled data, to evaluate the association between constipation and obesity in American adults aged 20 and above. Through the comparison of various obesity indicators, we aim to pinpoint which ones are most closely associated with the risk of constipation, thus providing valuable insights for clinical prevention and treatment strategies, guiding clinical practice, and informing future research directions.

Methods

Data source and participants

The National Health and Nutrition Examination Survey (NHANES), conducted by the National Center for Health Statistics under the Centers for Disease Control and Prevention (Atlanta, Georgia, USA), is a cross-sectional study focusing on a nationally representative sample of the non-institutionalized US population. Employing a complex, stratified, multistage, probability cluster design, it selects non-institutionalized individuals from the US. All participants gave written informed consent, as mandated by the Ethics Review Committee of the National Center for Health Statistics. Our current analysis zeroes in on participants aged ≥ 20 years from three NHANES cycles, all of whom completed the intestinal health and dietary assessment questionnaire. From 2005–2010, out of the 31,034 NHANES participants, 13,531 filled out the dedicated questionnaire on intestinal health. After excluding pregnant individuals (n = 383), those diagnosed with colorectal cancer (n = 95), and those with missing data (n = 1,268), the study considered a final sample of 11,785 participants, split between 5,981 males and 5,804 females. The flow chart of the systematic selection process is shown in Fig. 1.

Measures

Adiposity measures

At the Mobile Examination Center, trained health technicians employ standardized methods detailed in a procedural manual to measure weight, height, and waist circumference. Each measurement session involves a health technician and an accompanying recorder. Health technicians also draw blood samples from the antecubital vein of all study participants. Examination indicators encompass high-density lipoprotein cholesterol (HDL) and fasting triglycerides (TG). To investigate and compare the correlations between various obesity indices and the presence of constipation, we utilized data from the NHANES database and selected six distinct anthropometric indices as obesity indicators: BMI, VAI, WWI, WSR, LAP, and WC. These six indices were chosen for their ease of measurement and widespread recognition [1315].
BMI is calculated using the following formula: BMI = weight (kg) / (height (m))^2. Based on BMI values, the World Health Organization classifies individuals as underweight (BMI < 18.5), normal weight (BMI 18.5–24.9), overweight (BMI 25–29.9), or obese (BMI ≥ 30). VAI is an integrated index that considers BMI, WC, TG, and HDL: for males, VAI = [WC (cm) / 39.68 + (1.88 * BMI)] * (TG (mmol/L) / 1.03) * (1.31 / HDL (mmol/L)); for females, VAI = [WC (cm) / 36.58 + (1.89 * BMI)] * (TG (mmol/L) / 0.81) * (1.52 / HDL (mmol/L)) [16]. WWI is computed as WC in centimeters divided by the square root of weight in kilograms. WSR represents the ratio of waist circumference to height [17]. LAP serves as an indicator to assess lipid accumulation, incorporating WC and triglycerides (TG): for males, LAP = (WC (cm) - 65) * TG (mmol/L); for females, LAP = (WC (cm) - 58) * TG (mmol/L) [18]. WC, VAI, WWI, and WSR each employ the 25th, 50th, and 75th percentiles (P25, P50, and P75) as threshold values. Central obesity is defined as a waist circumference (WC) ≥ 88 cm in females or ≥ 102 cm in males.

Constipation

NHANES conducted an intestinal health questionnaire from 2005 to 2010 during which data regarding stool frequency and consistency were recorded. This data played a pivotal role in defining constipation within the scope of this study. Notably, both of these measures were considered in the establishment of constipation criteria.
The primary definition of constipation was derived from participants’ self-reports concerning their usual stool characteristics, categorized as either Type 1 (hard, nut-like lumps) or Type 2 (lumpy, sausage-like stools) on the Bristol Stool Form Scale.
Additionally, a secondary definition of constipation was formulated based on participants’ responses to a specific question regarding stool frequency: “How often do you typically have a bowel movement per week?” Individuals falling under the constipated category were those who reported having bowel movements less than or equal to two times per week. Conversely, individuals with bowel movements occurring more than twice a week were classified as non-constipated.

Covariates

Several variables were evaluated as potential covariates due to their hypothesized or previously demonstrated association with constipation and obesity. These variables included the intake of energy [8], fiber [9], fat [10], phosphorus [11], magnesium [12] and selenium [13], as well as factors like depression scores [14], sleep duration [15], and exercise levels [16]. In our sociodemographic assessment, we considered age (treated as a categorical variable), gender, race/ethnicity (spanning categories from Mexican–American to non-Hispanic Black), educational attainment, and PIR (with two distinct ranges).
For behavioral risk factors, we examined smoking and drinking habits, physical activity intensity, and sleep patterns. We categorized individuals into never smokers and regular smokers based on their lifetime cigarette consumption. Those consuming a minimum of 12 alcoholic drinks annually were labeled as drinkers. Physical activities were bifurcated into intense (e.g., heavy lifting or construction work causing significant breath or heart rate increase) and non-intense types. Sleep duration was segmented into four categories, ranging from very short to extended sleep durations.
Medical conditions were also considered. Diabetes was identified based on a physician’s diagnosis, while hypertension was identified through professional medical advice. Depression status was ascertained using the NHANES mental health questionnaire, specifically relying on the Patient Health Questionnaire 9 scale, a validated tool for depression assessment [17].

Statistical analyses

We conducted data analysis using R (version 3.4.3, 2021–12-21, R Foundation; http://​www.​r-project.​org) and Stata (MP 17.0). Considering sampling weights, we estimated sampling errors through Taylor series linearization. Using NHANES census data from 2005–2010, we summarized the weighted prevalence of US adults in proportional units. We examined the baseline characteristics of study individuals through descriptive analysis, stratifying by the presence of constipation. Continuous variables were presented as weighted means ± standard errors (SE), while categorical variables were represented as counts (weighted percentages, %). Chi-square statistics were used for categorical variables, and analysis of variance for continuous variables.
To assess the associations between various obesity indices and the prevalence of constipation, we employed a survey multivariable logistic regression to calculate adjusted odds ratios (AORs) and 95% confidence intervals (CIs). Our analysis consisted of three models. The crude model did not adjust for categorical variables. Model 2 adjusted for age, gender, and ethnicity. Model 3, based on Model 2, further adjusted for gender, age, ethnicity, education, ratio, diabetes, smoking, alcohol use, hypertension, sleep duration, depression, physical activity, and dietary intake of energy, protein, carbohydrates, dietary fiber, total fat, total saturated fatty acids, total monounsaturated fatty acids, and total polyunsaturated fatty acids. P < 0.05 was considered statistically significant.
To study the relationship between six obesity indices and constipation, we employed a restricted cubic spline regression model with three knots located at the 25th, 50th, and 75th percentiles. Our analysis further considered the relationship between constipation and various obesity indices, stratified by gender, age, ethnicity, education, PIR, diabetes, smoking status, alcohol consumption, hypertension, sleep duration, depression, and vigorous physical activity.

Results

Demographic characteristics

The demographic characteristics, as shown in Table 1, encompassed a total of 11,785 participants (5,981 males and 5,804 females) aged 20 and above who were surveyed over six NHANES cycles. The unweighted and weighted prevalence rates for the total participants in the sample were 9.83% and 9.12%
Table 1
Baseline characteristics of the study population from national health and nutrition examination survey 2005–2010 (using the stool consistency definition of constipation), weighted
Characteristics
Overall [n(%)]
Constipation [n(%)]
No constipation [n(%)]
P-valueb
Total participants
11,785 (100)
9.1
90.9
< 0.001
Sex
   
< 0.001
 Male
5981 (49.6)
25.6
52.0
 
 Female
5804 (50.4)
74.4
48.0
 
Age (years)
46.00 ± 0.34
43.00 ± 0.55
46.00 ± 0.36
< 0.001
 20–29
1939 (18.3)
25.3
17.6
< 0.001
 30–39
1986 (18.4)
17.1
18.5
 40–49
2162 (21.5)
20.3
21.6
 50–59
1878 (19.3)
17.8
19.5
 60–69
1927 (12.2)
9.6
12.5
 70–79
1255 (7.0)
5.9
7.1
 > 80
638 (3.3)
3.9
3.2
Ethnicity
   
< 0.001
 Mexican American
2091 (7.8)
8.1
7.7
 
 Other Hispanic
936 (4.1)
4.8
4.0
 
 Non-Hispanic White
6038 (72.9)
67.0
73.5
 
 Non-Hispanic Black
2259 (10.2)
15.9
9.6
 
 Other Race - Including Multi-Racial
461 (5.1)
4.2
5.2
 
Education
   
< 0.001
 Below high school
3136 (17.3)
21.2
16.9
 
 High school
2820 (24.1)
29.6
23.5
 
 Above high school
5829 (58.6)
49.2
59.6
 
PIR
3.23 ± 0.04
2.34 ± 0.07
3.33 ± 0.04
< 0.001
 < 2
5297 (31.2)
42.4
30.1
< 0.001
 ≥ 2
6488 (68.8)
57.6
69.9
Diabetes
   
0.051
 Yes
1270 (7.6)
7.9
7.5
 
 No
10,300 (90.8)
91.5
90.7
 
 Borderline
215 (1.7)
0.7
1.8
 
Smoking
   
< 0.001
 Yes
5675 (47.6)
42.2
48.1
 
 No
6110 (52.4)
57.8
51.9
 
Alcohol use
   
< 0.001
 Yes
8586 (77.0)
66.9
78.0
 
 No
3199 (23.0)
33.1
22.0
 
Hypertension
   
0.015
 Yes
4040 (30.0)
26.7
30.3
 
 No
7745 (70.0)
73.3
69.7
 
Sleep duration
   
< 0.001
 < 5 h/night
685 (4.9)
6.4
4.7
 
 5–6 h/night
3931 (31.3)
36.1
30.8
 
 Normal
6343 (57.4)
49.2
58.2
 
 ≥ 9 h/night
826 (6.5)
8.3
6.3
 
Depression
   
< 0.001
 No
10,600 (91.7)
84.5
92.5
 
 Yes
1185 (8.3)
15.5
7.5
 
Physical activity
   
0.025
 Vigorous physical activity
2831 (27.0)
22.8
27.4
 
 No vigorous activity
8954 (73.0)
77.2
72.6
 
Daily dietary intake
 Energy (kcal/d)
2027 (1511,2722)
1796 (1361,2440)
2047 (1527,2758)
< 0.001
 Protein (gm/d)
77.3 (55.2,106.1)
65.4 (47.0,91.3)
78.4 (56.2,107.6)
< 0.001
 Carbohydrate (gm/d)
240.4 (176.0,326.3)
227.8 (168.4,307.3)
241.6 (176.9,328.5)
< 0.001
 Dietary fiber (gm/d)
14.4 (9.7,20.8)
12.4 (7.8,17.9)
14.7 (9.9,21.1)
< 0.001
 Total fat (gm/d)
75.6 (51.0,107.4)
66.5 (44.0,93.1)
76.8 (52.1,108.6)
< 0.001
 Total saturated fatty acids (gm/d)
24.3 (15.7,36.0)
21.8 (13.9,31.7)
24.7 (16.0,36.4)
< 0.001
 Total monounsaturated fatty acids (gm/d)
27.3 (18.2,39.6)
23.4 (15.4,34.6)
27.8 (18.3,40.1)
< 0.001
 Total polyunsaturated fatty acids (gm/d)
15.7 (10.0,23.3)
13.4 (8.0,19.9)
15.9 (10.2,23.5)
< 0.001
 Cholesterol (mg/d)
227 (134,384)
194 (111,332)
231 (137,390)
< 0.001
 Phosphorus (mg/d)
1276 (927,1744)
1101 (787,1525)
1297 (944,1764)
< 0.001
 Magnesium (mg/d)
279 (204,375)
236 (168,323)
283 (208,382)
< 0.001
 Selenium (mcg/d)
103 (70,143)
88 (60,119)
105 (71,146)
< 0.001
 Caffeine (mg/d)
135 (36,281)
92 (15,240)
140 (39,284)
0.186
Continuous variables are presented as mean ± SE or median (interquartile range), and categorical variables are presented as n (%)
SE Standard error
bP-value based on survey t-test for binominal groups, and based on chi-square test in the qualitative variables. P-values in bold indicate statistical significance
The mean age of all participants was 46.00 ± 0.34 years. The majority fell into the 40–49 age group, comprising 2,162 individuals (21.5%), followed by the 30–39 age group with 1,986 individuals (18.4%). The distribution of participants was relatively even across age groups.
Regarding ethnic backgrounds, most of the participants were non-Hispanic white, totaling 6,038 individuals (72.9%). This was followed by 2,259 individuals (10.2%) of Non-Hispanic Black descent, 2,091 individuals (7.8%) of Mexican American descent, and 1,397 other individuals (9.2%).
Participants defined as constipated exhibited certain characteristics. They were more likely to be female (74.4%), non-Hispanic white (67.0%), have higher education levels (49.2%), lower poverty income ratio (57.6%), non-diabetic (91.5%), non-smoker (57.8%), be drinkers (66.9%), non-hypertensive (73.3%), have moderate sleep duration (49.2%), non-depressed (84.5%), non-vigorous exercisers (77.2%), and had lower daily intake of energy, protein, carbohydrate, dietary fiber, total fat, total saturated fatty acids, total monounsaturated fatty acids, total polyunsaturated fatty acids, cholesterol, phosphorus, magnesium, and selenium (P < 0.05).

Relationship between obesity and constipation

After adjusting for weighted data in the crude model, we observed that three indices were positively associated with the risk of constipation: BMI (COR = 1.60, 95% CI: 1.29, 1.98), WSR (COR = 1.33, 95% CI: 1.05, 1.67), and LAP (COR = 1.25, 95% CI: 1.03, 1.52). Conversely, another index, WWI (COR = 0.41, 95% CI: 0.32, 0.52), exhibited a negative correlation with constipation (Fig. 2).
Upon further adjustment and weighting for age, gender, race/ethnicity, and other relevant covariates, we used the lowest quartile of obesity indices as the reference. It was observed that constipation was significantly positively associated with obesity indices in the third and fourth quartiles, including WSR (AOR = 1.31, 95% CI: 1.01, 1.70) and WSR (AOR = 1.36, 95% CI: 1.06, 1.74). Conversely, constipation was significantly negatively associated with obesity indices in the fourth quartile, specifically VAI (AOR = 0.76, 95% CI: 0.60, 0.96), as well as the second, third, and fourth obesity indices: WWI (AOR = 0.78, 95% CI: 0.60, 1.00), WWI (AOR = 0.59, 95% CI: 0.48, 0.74), and WWI (AOR = 0.65, 95% CI: 0.49, 0.85). Additionally, when using BMI as the reference value, constipation was found to be positively associated with obesity indices in the fourth quartile, represented by BMI (AOR = 1.51, 95% CI: 1.20, 1.89).
In the fully adjusted and weighted model, where we still used the lowest quartile of obesity indices as the reference, we found significant positive associations with obesity indices in the third quartile, such as WSR (AOR = 1.44, 95% CI: 1.11, 1.89) and LAP (AOR = 1.25, 95% CI: 1.01, 1.54), as well as obesity indices in the fourth quartile, particularly WSR (AOR = 1.62, 95% CI: 1.24, 2.12). Furthermore, constipation exhibited a significant negative association with central obesity indices, denoted as central obesity (AOR = 0.74, 95% CI: 0.61, 0.89), and with obesity indices in the third quartile, specifically WWI (AOR = 0.65, 95% CI: 0.48, 0.88), and obesity indices in the fourth quartile, including WWI (AOR = 0.59, 95% CI: 0.46, 0.75) and LAP (AOR = 1.25, 95% CI: 1.01, 1.54). Moreover, when using BMI as the reference, constipation exhibited a significant positive association with obesity indices, represented as BMI (AOR = 1.68, 95% CI: 1.31, 2.15).
In the restricted cubic spline analysis within the fully adjusted model, we identified that BMI, WSR, and LAP had a significant non-linear relationship with constipation. On the other hand, WWI and WC showed a significant linear relationship with constipation, with WWI negatively correlated with constipation, while WC was positively correlated with constipation. Importantly, in this study, neither RCS (Fig. 4) nor logistic regression revealed a significant relationship between VAI and the prevalence of constipation.

Stratified analysis of obesity and constipation

Figure 3 presents a subgroup analysis of six obesity indices and their association with constipation. Stratified analysis reveals dose–response relationships between BMI, VAI, WWI, WSR, LAP, and WC, and the occurrence of constipation (Fig. 4). These associations remained consistent across various subgroups stratified by gender, age, race, education level, poverty ratio, diabetes, smoking, hypertension, sleep duration, depression, and vigorous exercise.

Discussion

This groundbreaking large-scale study explores the correlations between various obesity indices and constipation in the American population. After adjusting for relevant variables, we identified different trends in various obesity indices and constipation. BMI is widely used in epidemiological studies to assess the risk of health outcomes associated with different weight levels. In this study, RCS analysis identified a significant non-linear relationship between BMI and constipation. As BMI increases, the occurrence of constipation decreases. However, when BMI exceeds 28 kg/m2, the risk of constipation significantly increases.
WSR also exhibits a significant non-linear relationship with constipation. When WSR is greater than, 58.3 there is a significant increase in the risk of constipation compared to the first quartile (p < 0.05). Interestingly, a previous survey of the Dunedin population in New Zealand found no significant relationship between WSR and constipation [7].
LAP demonstrates an “n”-shaped trend in relation to the risk of constipation, with the highest risk occurring in the third quartile of LAP. Several potential mechanisms may help explain this observed trend. In contrast, a study involving 354 constipated patients showed a significant negative correlation between BMI and colonic transit time [19]. Specifically, constipated patients in the overweight group had shorter rectosigmoid and total colonic transit times compared to patients in the normal BMI group. This relationship may be attributed to bile acid metabolism dynamics. Improvement in colonic transit, stool consistency, and frequency of defecation was observed when functional constipation patients were treated with drugs that affect the levels and transport of bile acids.
A study of 120,000 New Zealand residents found a negative association between overweight and abdominal pain and constipation (OR 0.4, 95% CI 0.2–0.9; p = 0.02). The research also revealed a significant negative correlation between WWI > 0.015 and the onset of constipation. When central obesity is absent, the risk of constipation decreases (P < 0.05). BMI is the traditional parameter for assessing obesity; however, it cannot differentiate between lean mass and fat mass [2022]. WC has been proposed as an alternative measure to indirectly assess visceral fat accumulation. Park et al. introduced a new obesity index called weight-adjusted waist index (WWI), which standardizes waist circumference (WC) by body weight and is easy to measure. Therefore, WWI can capture the benefits of WC and attenuate its correlation with BMI, primarily reflecting central obesity independent of body weight.
Many studies have assessed the relationship between constipation and the risk of overweight/obesity; however, the results are controversial. Some studies have proposed opposing conclusions. Pawlowska found no significant differences in weight/BMI between FC patients and control groups [23]. Furthermore, three other studies indicated that individuals with chronic constipation were more likely to be underweight [2022].
Currently, there is still a lack of large-scale relevant studies on the relationship between VAI, WWI, LAP, WC, and the risk of constipation. Our study also has certain limitations. It is a cross-sectional study; therefore, the absence of cohort studies may lead to a relatively high risk of bias. Further research should focus on investigating the potential mechanisms underlying the association between these two conditions and establish systematic approaches for the treatment of FC and prevention of overweight/obesity to reduce the development of these two conditions. Therefore, carefully planned longitudinal studies are essential to firmly establish the relationship and causality between BMI and constipation.

Conclusion

In summary, this large-scale pioneering study has examined the relationship between various obesity indicators, such as BMI, VAI, WWI, WSR, LAP, and central obesity, and their association with constipation. These indicators collectively provide a comprehensive assessment of obesity from different bodily perspectives. The study notably found that a reduction in BMI, WSR, LAP and WC is associated with a decreased risk of constipation. In contrast, elevated levels of WWI correlate with a lower constipation risk, a trend that persists even after adjusting for a broad spectrum of variables. These findings not only aid individuals in managing constipation through self-care but also offer healthcare professionals novel insights into the most appropriate treatment of constipation in patients with varying levels of obesity.

Acknowledgements

I extend my sincere gratitude for the generous funding provided by the National Natural Science Foundation of China (82374456, 82074439 and 82274514) and the Jiangsu graduate research and Practice Innovation project (SJCX22_0763) in this formal setting. Additionally, I would like to express my heartfelt appreciation to Dr. Huang Jicheng for his invaluable support of this project.

Disclosure

The authors declared no conflicts of interest.

Declarations

This research analyzed de-identified information downloaded from the National Health and Nutrition Examination Survey public database. The National Center for Health Statistics Ethics Review Committee granted ethics approval. All methods were carried out in accordance with relevant guidelines and regulations (declaration of Helsinki). All individuals provided written informed consent before participating in the study.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Vincent AD, Wang XY, Parsons SP, Khan WI, Huizinga JD. Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin. Am J Physiol Gastrointest Liver Physiol. 2018;315(5):G896–907.CrossRefPubMed Vincent AD, Wang XY, Parsons SP, Khan WI, Huizinga JD. Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin. Am J Physiol Gastrointest Liver Physiol. 2018;315(5):G896–907.CrossRefPubMed
2.
Zurück zum Zitat Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.CrossRefPubMed Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.CrossRefPubMed
4.
Zurück zum Zitat Pecora P, Suraci C, Antonelli M, De Maria S, Marrocco W. Constipation and obesity: a statistical analysis. Boll Soc Ital Biol Sper. 1981;57(23):2384–8.PubMed Pecora P, Suraci C, Antonelli M, De Maria S, Marrocco W. Constipation and obesity: a statistical analysis. Boll Soc Ital Biol Sper. 1981;57(23):2384–8.PubMed
5.
Zurück zum Zitat Alsheridah N, Akhtar S. Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study. BMC Cancer. 2018;18:1–10.CrossRef Alsheridah N, Akhtar S. Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study. BMC Cancer. 2018;18:1–10.CrossRef
6.
Zurück zum Zitat Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ 3rd. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ 3rd. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.CrossRefPubMed
7.
Zurück zum Zitat Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am Coll Gastroenterol. 2004;99(9):1807–14.CrossRef Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am Coll Gastroenterol. 2004;99(9):1807–14.CrossRef
8.
Zurück zum Zitat Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMed Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–80.CrossRefPubMed
9.
Zurück zum Zitat Lim Y, Jo K, Ha HS, Yim HW, Yoon KH, Lee WC, et al. The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study. Osteoporos Int. 2017;28(4):1453–9.CrossRefPubMed Lim Y, Jo K, Ha HS, Yim HW, Yoon KH, Lee WC, et al. The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study. Osteoporos Int. 2017;28(4):1453–9.CrossRefPubMed
10.
Zurück zum Zitat Matos LN, Giorelli GDV, Dias CB. Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med J. 2011;129:30–5.CrossRefPubMedPubMedCentral Matos LN, Giorelli GDV, Dias CB. Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med J. 2011;129:30–5.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira PdA, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9(7):e103499.CrossRefPubMedPubMedCentral Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira PdA, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9(7):e103499.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Wiltgen D, Benedetto I, Mastella L, Spritzer P. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726–31.CrossRefPubMed Wiltgen D, Benedetto I, Mastella L, Spritzer P. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726–31.CrossRefPubMed
13.
Zurück zum Zitat Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among Thai adults. Obes Res Clin Pract. 2008;2(3):215–23.CrossRefPubMedPubMedCentral Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among Thai adults. Obes Res Clin Pract. 2008;2(3):215–23.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Okorodudu DO, Jumean M, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–9.CrossRef Okorodudu DO, Jumean M, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–9.CrossRef
15.
Zurück zum Zitat Cheong KC, Yusoff AF, Ghazali SM, Lim KH, Selvarajah S, Haniff J, Khor GL, Shahar S, Abd Rahman J, Zainuddin AA. Optimal BMI cut-off values for predicting diabetes, hypertension and hypercholesterolaemia in a multi-ethnic population. Public Health Nutr. 2013;16(3):453–9.CrossRefPubMed Cheong KC, Yusoff AF, Ghazali SM, Lim KH, Selvarajah S, Haniff J, Khor GL, Shahar S, Abd Rahman J, Zainuddin AA. Optimal BMI cut-off values for predicting diabetes, hypertension and hypercholesterolaemia in a multi-ethnic population. Public Health Nutr. 2013;16(3):453–9.CrossRefPubMed
16.
Zurück zum Zitat Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, Group AS. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRefPubMedPubMedCentral Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, Group AS. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Group DS, Nyamdorj R. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity. 2008;16(7):1622–35.CrossRef Group DS, Nyamdorj R. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity. 2008;16(7):1622–35.CrossRef
18.
Zurück zum Zitat Onat A, Avcı GŞ, Barlan M, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004;28(8):1018–25.CrossRef Onat A, Avcı GŞ, Barlan M, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004;28(8):1018–25.CrossRef
19.
Zurück zum Zitat Bouchoucha M, Fysekidis M, Rompteaux P, Airinei G, Sabate JM, Benamouzig R. Influence of age and body mass index on total and segmental colonic transit times in constipated subjects. J Neurogastroenterol Motil. 2019;25(2):258–66.CrossRefPubMedPubMedCentral Bouchoucha M, Fysekidis M, Rompteaux P, Airinei G, Sabate JM, Benamouzig R. Influence of age and body mass index on total and segmental colonic transit times in constipated subjects. J Neurogastroenterol Motil. 2019;25(2):258–66.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Chao H-C, Chen S-Y, Chen C-C, Chang K-W, Kong M-S, Lai M-W, Chiu C-H. The impact of constipation on growth in children. Pediatr Res. 2008;64(3):308–11.CrossRefPubMed Chao H-C, Chen S-Y, Chen C-C, Chang K-W, Kong M-S, Lai M-W, Chiu C-H. The impact of constipation on growth in children. Pediatr Res. 2008;64(3):308–11.CrossRefPubMed
21.
Zurück zum Zitat Santucci NR, Hyman PE. Do functional gastrointestinal disorders affect growth and nutrition? J Pediatr. 2018;199:9–10.CrossRefPubMed Santucci NR, Hyman PE. Do functional gastrointestinal disorders affect growth and nutrition? J Pediatr. 2018;199:9–10.CrossRefPubMed
22.
Zurück zum Zitat Squires JE, Alonso EM, Ibrahim SH, Kasper V, Kehar M, Martinez M, Squires RH. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the diagnosis and management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2022;74(1):138–58.CrossRefPubMed Squires JE, Alonso EM, Ibrahim SH, Kasper V, Kehar M, Martinez M, Squires RH. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the diagnosis and management of pediatric acute liver failure. J Pediatr Gastroenterol Nutr. 2022;74(1):138–58.CrossRefPubMed
23.
Zurück zum Zitat Pawłowska K, Umławska W, Iwańczak B. A link between nutritional and growth states in pediatric patients with functional gastrointestinal disorders. J Pediatr. 2018;199:171–7.CrossRefPubMed Pawłowska K, Umławska W, Iwańczak B. A link between nutritional and growth states in pediatric patients with functional gastrointestinal disorders. J Pediatr. 2018;199:171–7.CrossRefPubMed
Metadaten
Titel
Multiple obesity indices suggest a close relationship between obesity and constipation: evidence from NHANES
verfasst von
Nengjun Xiang
Lulu Xu
Haihua Qian
Dan Zhang
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18647-y

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe